QbD Group
    Regulatory Update

    MDCG 2024-12 released

    On October 7th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance and templates for the assessment of Corrective and Preventive Action (CAPA) plans, intended for conformity assessment bodies, notified bodies, designating authorities, and Joint Assessment Teams involved in the implementation of Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR). It includes detailed sections on corrections, root cause analysis, corrective and preventive actions, and actions for verification of effectiveness.

    It includes detailed sections on corrections, root cause analysis, corrective and preventive actions, and actions for verification of effectiveness. The document also provides templates in Annex I and Annex II to facilitate a consistent and efficient CAPA review process.

    MDCG 2024-12: Corrective and preventive action (CAPA) plan assessment: guidance and templates for conformity assessment bodies, notified bodies, designating authorities and joint assessment teams

    What does it mean to you?

    MDCG 2024-12 does not directly target manufacturers of IVDs and medical devices. Nonetheless, corrective actions to be taken by notified bodies may have an impact on existing certificates for such manufacturers.

    Share this article

    Subscribe to the latest updates in life science

    Expert perspectives delivered to your inbox — pick your interests.

    No spam, ever. Unsubscribe anytime.